Name
OÜ Antegenes
Registry code
14489312
VAT number
EE102307795
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
15.05.2018 (6)
Financial year
01.01-31.12
Capital
3 251.39 €
Activity
86221 - Provision of specialised medical treatment
170 880 €
-768 463 €
-450%
3 327 €
(estimate is approximate)
591 765 €
14
Submitted
No tax arrears
-130%
-66%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Berit Kolk 18.10.1990 (34) | 2% - 75.00 EUR | Board member | - | |
| Biogenoma OÜ 14849638 | 2% - 75.00 EUR | - | - | |
| Forestec Eesti OÜ 11980355 | 2% - 71.55 EUR | - | - | |
| Vain & Partnerid OÜ 10324593 | 2% - 71.55 EUR | - | - | |
| Rochna Invest OÜ 16154403 | 2% - 71.55 EUR | - | - | |
| 12 Capital OÜ 12211570 | 2% - 71.55 EUR | - | - | |
| RD Kinnisvara OÜ 12520851 | 20% - 639.31 EUR | - | - | |
| Einberi OÜ 10843308 | 2% - 57.24 EUR | - | - | |
| Osaühing Mersok 10508811 | 1% - 28.62 EUR | - | - | |
| Tarmo-Tanel Padrik 09.02.1969 (55) | 1% - 25.00 EUR | - | - | |
| Astronaut OÜ 11199447 | 1% - 21.47 EUR | - | - | |
| OÜ Personaalmeditsiin 11221767 | 56% - 1 825.00 EUR | - | - | Founder |
| Uniment Health OÜ 16326531 | 0% - 14.31 EUR | - | - | |
| Omanikukonto: EIKI RUMP 21.11.1974 (50) | 0% - 14.31 EUR | - | - | |
| Brugal Invest OÜ 12629016 | 0% - 14.31 EUR | - | - | |
| Arbuust OÜ 16210277 | 0% - 14.31 EUR | - | - | |
| Peeter Padrik 02.02.1966 (58) | - | Board member | Indirect ownership |
| 2019 14.04.2020 | 2020 17.06.2021 | 2021 08.04.2022 | 2022 01.06.2023 | 2023 31.05.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 1 045 € | 19 123 € | 187 384 € | 33 570 € | 170 880 € |
| Net profit (loss) for the period | -18 954 € | -168 596 € | -170 563 € | -698 196 € | -768 463 € |
| Profit Margin | -1814% | -882% | -91% | -2080% | -450% |
| Current Assets | 22 775 € | 17 790 € | 188 683 € | 1 488 332 € | 988 870 € |
| Fixed Assets | 153 036 € | 247 695 € | 240 136 € | 201 805 € | 172 570 € |
| Total Assets | 175 811 € | 265 485 € | 428 819 € | 1 690 137 € | 1 161 440 € |
| Current Liabilities | 27 144 € | 44 039 € | 45 436 € | 112 153 € | 176 138 € |
| Non Current Liabilities | 175 500 € | 167 500 € | 0 € | 217 755 € | 393 537 € |
| Total Liabilities | 202 644 € | 211 539 € | - | 329 908 € | 569 675 € |
| Share Capital | - | - | - | - | - |
| Equity | -26 833 € | 53 946 € | 383 383 € | 1 360 229 € | 591 765 € |
| Employees | 2 | 5 | 7 | 11 | 14 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 11 910.74 € | 69 189.15 € | 73 843.13 € | 17 |
| 2023 Q4 | 79 788.98 € | 65 024.33 € | 65 252.53 € | 18 |
| 2023 Q3 | 121 048.29 € | 65 073 € | 59 279.93 € | 16 |
| 2023 Q2 | 99 218.88 € | 70 466.67 € | 66 131 € | 14 |
| 2023 Q1 | 26 542.34 € | 52 406.18 € | 54 344.88 € | 16 |
| 2022 Q4 | 33 522.51 € | 45 352.68 € | 45 160.49 € | 18 |
| 2022 Q3 | 15 284.56 € | 33 350.12 € | 35 748.18 € | 16 |
| 2022 Q2 | 4 951.72 € | 27 748.48 € | 29 328.32 € | 12 |
| 2022 Q1 | 7 262.69 € | 26 532.93 € | 27 020.2 € | 10 |
| 2021 Q4 | 729.08 € | 22 211.92 € | 23 892.66 € | 9 |
| 2021 Q3 | 27 757.42 € | 26 766 € | 24 511.81 € | 9 |
| 2021 Q2 | 12 288.23 € | 23 087.22 € | 22 396.44 € | 9 |
| 2021 Q1 | 2 139.53 € | 22 247.67 € | 23 891.92 € | 7 |
| 2020 Q4 | - | 19 148.42 € | 20 757.25 € | 8 |
| 2020 Q3 | - | 16 129.06 € | 17 450.65 € | 8 |
| 2020 Q2 | - | 10 276.23 € | 11 131.66 € | 7 |
| 2020 Q1 | - | 6 705.08 € | 7 269.41 € | 4 |
